DISS

Department of Health Sciences

Manager ambientale per la gestione del decommissioning e dei rifiuti radioattivi in ambito sanitario, industriale e di ricerca

Course held by the Department of Health Sciences at the Università degli Studi del Piemonte Orientale, a Master’s degree in Environmental Manager for decommissioning and management of radioactive waste in health, industrial and research sectors. The course is held in collaboration with the Società Gestione Impianti Nucleari per Azioni (Italian Company for Management of Nuclear Plants) and is sponsored by University Hospitals “Maggiore della Carità” of Novara and “SS. Antonio e Biagio e Cesare Arrigo” of Alessandria.

 

Duration: one year

SIMNOVA - Centro interdipartimentale di Didattica Innovativa e di Simulazione in Medicina e Professioni Sanitarie

Il Centro Interdipartimentale di Didattica Innovativa e di Simulazione in Medicina e Professioni Sanitarie (SIMNOVA) nasce formalmente nel giugno 2014 presso l’Università del Piemonte Orientale. Il SIMNOVA è istituito allo scopo di svolgere attività di alta formazione, ricerca e servizi in ambito sanitario, con particolare attenzione all’uso della simulazione come strumento per innovare i programmi di formazione, migliorare la qualità della cura, ridurre il rischio clinico ed aumentare la sicurezza per i pazienti.

- Smart and functional nanobiomaterials for sense, response and remote control of biological threats to enhance on cartilage tissue regeneration

The project sets out to study new techniques for the the regeneration of cartilage tissue in the knee, in the event of minor or major damage.

These technologies include bioinks with stem cells to be used for customised 3D printing on the basis of MR images.

The technologies developed include antibacterial and anti-inflammation drugs. The project is designed to insert biosensors within the regenerated cartilage tissue in order to control its functioning from outside thanks to the ‘Internet of things’ approach.

- Triggering neuroprotective pathways to prevent neurodegeneration: role of estrogen receptor beta/neuroglobin signaling in Huntington disease

Huntingdon’s Disease is a hereditary condition affecting the central nervous system and causing the degeneration of neurons in selected cerebral regions. In the absence of an effective cure, the identification of neuroprotective molecules represents a promising way to develop a therapy.

- From pathobioLogy to synoviA on chip: driving rheuMatoId arthritis to the precisioN medicine GOal

Rheumatoid arthritis (RA) is an autoimmune disorder, characterised by inflammation of the synovial (joint-lining) membrane, which affects 1% of the population. If not treated, it can lead to joint deformity and permanent disability. There is not yet a cure for RA but prompt treatment with anti-rheumatic drugs (DMARD) can slow down its development, protecting joints from permanent damage.